Evaluating the New Trauma Score (NTS) for Improved Mortality Prediction
Launched by AL-NAHRAIN UNIVERSITY · Dec 10, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to predict whether trauma patients are at risk of dying after being admitted to the emergency department. It focuses on a tool called the New Trauma Score (NTS), which is an updated version of an older tool known as the Revised Trauma Score (RTS). Researchers want to find out if the NTS is better at predicting outcomes for patients with different types of trauma, such as injuries from accidents or attacks.
To be part of the study, participants need to be trauma patients aged 18 and older who are admitted to the emergency department and can give consent. The trial will track their health and outcomes during their hospital stay. Patients will be assessed using both the NTS and RTS scores when they arrive to see how well each score predicts their recovery. It's important to note that patients under 18, pregnant women, and those who cannot provide consent will not be included in the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All trauma patients (including blunt, penetrating, and traumatic brain injury) admitted to the emergency department.
- • Patients presenting with varying degrees of trauma (mild to severe).
- • Patients (or their legal representatives) who provide informed consent to participate in the study.
- • Trauma patients admitted to the emergency department.
- • Patients who are assessed using both the Revised Trauma Score (RTS) and the New Trauma Score (NTS) upon admission to the emergency department.
- Exclusion Criteria:
- • Patients under 18 years old.
- • Pregnant women, due to the potential complications and challenges in trauma assessment.
- • Patients who refuse to give consent to participate in the study or whose legal guardians refuse on their behalf.
- • Trauma patients transferred from other hospitals.
- • Patients with incomplete medical records or missing key data required for trauma score calculation.
About Al Nahrain University
Al-Nahrain University is a leading academic institution dedicated to advancing medical research and education in Iraq. With a focus on innovative clinical trials, the university aims to enhance healthcare outcomes through rigorous scientific investigation and collaboration with local and international partners. Its commitment to ethical research practices and adherence to regulatory standards positions Al-Nahrain University as a pivotal contributor to the development of new therapeutic interventions and the overall improvement of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baghdad, Kadhimiya, Iraq
Patients applied
Trial Officials
Mohammad A. Hamdawi, Lecturer of general surgery
Study Director
College Of Medicine - Nahrain University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported